Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats

키워드

참고문헌 (48)

1. Touyz RM., "Role of magnesium in the pathogenesis of hypertension", Mol Aspects Med, 24, pp.107~136 (2003)
2. Laurant P, "Timecourse of the change in blood pressure level in magnesium- deficient Wistar rats", Br J Nutr, 82, pp.243~251 (1999)
3. Adrian M, "A long-term moderate magnesium-deficient diet aggravates cardiovascular risks associated with aging and increases mortality in rats", J Hypertens, 26, pp.44~52 (2008)
4. Fox C, "Magnesium: its proven and potential clinical significance", South Med J, 91, pp.1195~1201 (2001)
5. Swaminathan R., "Magnesium metabolism and its disorders", Clin Biochem Rev, 24, pp.47~66 (2003)
6. Sontia B, "Role of magnesium in hypertension", Arch Biochem Biophys, 458, pp.33~39 (2007)
7. Berthon N, "Magnesium supplementation and deoxycorticosterone acetate: salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1", Can J Physiol Pharmacol, 80, pp.553~561 (2002)
8. Blache D, "Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats", Free Radic Biol Med, 41, pp.277~284 (2006)
9. Touyz RM, "Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension", Am J Physiol Heart Circ Physiol, 294, pp.1103~1118 (2008)
10. Shechter M, "Oral magnesium therapy improves endothelial function in patients with coronary artery disease", Circulation, 102, pp.2353~2358 (2000)
11. Touyz RM., "Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension", Med Hypotheses, 36, pp.140~141 (1991)
12. Saito N, "Magnesium, calcium and trace elements in spontaneously hypertensive rats", Clin Exp Pharmacol Physiol, 22, pp.212~214 (1995)
13. Makynen H, "Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity", Br J Pharmacol, 115, pp.1455~1462 (1995)
14. Evans GH, "Dietary magnesium does not affect blood pressure in spontaneously hypertensive rats", Clin Exp Hypertens A, 11, pp.619~632 (1989)
15. Berthelot A, "Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat", J Am Coll Nutr, 2, pp.343~353 (1983)
16. Touyz RM, "Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats", Am J Hypertens, 12(8), pp.757~765 (1999)
17. Laurant P, "Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension", J Hypertens, 18, pp.1177~1191 (2000)
18. Touyz RM, "Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms", J Biol Chem, 276, pp.13657~13663 (2001)
19. Nadler JL, "Magnesium deficiency produces insulin resistance and increased thromboxane synthesis", Hypertension, 21(6), pp.1024~1029 (1993)
20. 박문향, "신생검 조직검사 진단양식의 실용 지침", Journal of Pathology and Translational Medicine, 44(6), pp.613~622 (2010), 대한병리학회
21. Resnick LM, "Serum ionized magnesium: relation to blood pressure and racial factors", Am J Hypertens, 10(12), pp.1420~1424 (1997)
22. Kesteloot H, "Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure: Belgian Interuniversity Research on Nutrition and Health", Hypertension, 12, pp.594~599 (1988)
23. Kisters K, "Decreased membrane Mg2+ concentrations in a subgroup of hypertensives: membrane model for the pathogenesis of primary hypertension", Am J Hypertens, 11(11), pp.1390~1393 (1998)
24. Kawano Y, "Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures", Hypertension, 32, pp.260~265 (1998)
25. Laurant P, "Dietary magnesium supplementation modif ies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats", J Nutr, 125, pp.830~841 (1995)
26. Sanjuliani AF, "Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients", Int J Cardiol, 56, pp.177~183 (1996)
27. Widman L, "The dose-dependent reduction in blood pressure through administration of magnesium: a double blind placebo controlled cross-over study", Am J Hypertens, 6, pp.41~45 (1993)
28. Cappuccio FP, "Lack of effect of oral magnesium on high blood pressure: a double blind study", Br Med J (Clin Res Ed), 291, pp.235~238 (1985)
29. Ferrara LA, "Long-term magnesium supplementation in essential hypertension", Cardiology, 81, pp.25~33 (1992)
30. Lind L, "Blood pressure response during long-term treatment with magnesium is dependent on magnesium status: a double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure", Am J Hypertens, 4, pp.674~679 (1991)
31. Barbagallo M, "Oral magnesium supplementation improves vascular function in elderly diabetic patients", Magnes Res, 23, pp.131~137 (2010)
32. Kisters K., "Oral magnesium supplementation improves borderline hypertension", Magnes Res, 24, pp.17~ (2011)
33. Rosanoff A, "Magnesium supplements may enhance the effect of antihypertensive medications in stage 1 hypertensive subjects", Magnes Res, 23, pp.27~40 (2010)
34. Hatzistavri LS, "Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension", Am J Hypertens, 22, pp.1070~1075 (2009)
35. Guerrero-Romero F, "The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial", J Hum Hypertens, 23, pp.245~251 (2009)
36. Ameen M, "A comparison of free intracellular calcium and magnesium levels in the vascular smooth muscle and striated muscle cells of the spontaneously hypertensive and Wistar Kyoto normotensive rat", Ann N Y Acad Sci, 639, pp.550~553 (1991)
37. Laurant P, "Effect of magnesium deficiency on blood pressure and mechanical properties of rat carotid artery", Hypertension, 33, pp.1105~1110 (1999)
38. Laurant P, "Inf luence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat", Eur J Pharmacol, 258, pp.167~172 (1994)
39. Touyz RM, "Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species", J Hypertens, 20, pp.2221~2232 (2002)
40. Altura BM, "Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium", J Appl Physiol, 72, pp.194~202 (1992)
41. Yanagisawa M, "A novel potent vasoconstrictor peptide produced by vascular endothelial cells", Nature, 332, pp.411~415 (1988)
42. Moncada S, "The role of prostacyclin in vascular tissue", Fed Proc, 38, pp.66~71 (1979)
43. Weglicki WB, "Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin", Mol Cell Biochem, 110, pp.169~173 (1992)
44. Briel RC, "Action of magnesium sulfate on platelet prostacyclin interaction and prostacyclin of blood vessels", Am J Obstet Gynecol, 153, pp.232~ (1985)
45. Ginn HE, "Aldosterone secretion in magnesium-deficient rats", Endocrinology, 80, pp.969~971 (1967)
46. Altura BM, "Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis", Cell Mol Biol Res, 41, pp.347~359 (1995)
47. Yanahira S, "Effects of lactitol-oligosaccharides on calcium and magnesium absorption in rats", J Nutr Sci Vitaminol, 43, pp.123~132 (1997)
48. Iseri LT, "French JH. Magnesium: nature’s physiologic calcium blocker", Heart J, 108, pp.188~193 (1984)

관련 논문AI추천